MT
Mary T Szela bought $160K of TLSI stock
Mary T Szela, CEO and President of TriSalus Life Sciences, Inc. (TLSI), bought 65,192 shares of TLSI stock worth $160K, per an SEC Form 4 filed Nov 19, 2026.
It was an open-market purchase.
The trade happened on Nov 17, 2026, 2 days before it was made public.
TLSI has moved -5.2% since the trade date, from $2.29 to $2.17 (Nov 19, 2026 close).
- Traded
- Nov 17, 2026
- Disclosed
- Nov 19, 2026
- Filing delay
- 2 days
- Price since
- -5.2%
- Role
- CEO and President
- Source
- SEC Form 4